Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Rectal Cancer
Interventions
BEHAVIORAL

watch and wait

patients with DNA mismatch repair-deficient or microsatellite instability-high distal rectal cancer accessed pathological complete response after 6 courses of PD-1 monoclonal antibody (200mg/Course/Q3w) therapy and start watch and wait.

Trial Locations (1)

Unknown

RECRUITING

Sun Yatsen University, Guangzhou

All Listed Sponsors
lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER